Home

Transforming Healthcare with Evidence

hayesinfo@hayesinc.com | 215-855-0615




Their Directory and additional products have played an important role in the development of our own medical policies.

Michael M. Siegel, MD
Molina Healthcare, Inc.

GTE Topics for Cancer

Topic GTE Synopsis GTE Report
ALK Gene Rearrangement Testing in NSCLC Pending
APC-Associated Polyposis Conditions
Cadherin 1 testing in Hereditary Diffuse Gastric Cancer
CancerTYPE ID Pending
CDKN2A Testing in Malignant Melanoma
Colosure
DecisionDx-GBM Pending
DecisionDx-UM
deCODE BreastCancer Pending
deCODE ProstateCancer
ERCC1 Testing in NSCLC
HERMark Breast Cancer Assay Pending
Ki-67 (MKI67) Proliferation Marker Testing in Breast Cancer Pending
MelanoSITE FISH Test for Diagnosis of Melanoma
Mammaprint
Oncotype DX (Breast Cancer)
Oncotype DX (Colon Cancer) Pending
miRInform Thyroid Pending
MYH-Associated Polyposis
Oncovue N/A *
OVA1 Ovarian Tumor Triage Test N/A *
OvaSure N/A *
Panexia Pending
PathFinderTG (Breast Cancer) N/A *
PathFinderTG (Pancreatic Cancer)
PCA3 Testing for Prostate Cancer
Peutz-Jeghers Syndrome
PreOvar KRAS-Variant Test N/A *
Previstage GCC Colorectal Cancer Staging Test
ProOnc TumorSourceDX
Proveri Prostate Cancer Assay (PPCA)
PTEN Gene Expression Testing
SPOT-Light HER2 CISH Kit
TargetNow Molecular Profiling Test N/A *
VeriStrat Pending

 

* Indicates insufficient evidence for full report.

Stay Connected!

To receive email newsletters, updates, and special offers from Hayes, enter your email and press Submit.
Email

Social Media

More